Semaglutide and liraglutide may reduce alcohol consumption in individuals with AUD owenhaskins Nov 14, 2024 2 min read A joint study by the University of Eastern Finland and Karolinska Institutet in Sweden has found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, were associated with fewer hospitalisations among individuals with alcohol use disorder (AUD)
However, some clinical studies in dogs have examined drugs similar to those in Ozempic, such as GLP-1 receptor agonists
Like semaglutide, tirzepatide dosage in units depends entirely on vial concentration
How Do Semaglutide and Tirzepatide Work
ABBREVIATIONS: ED emergency department EGD esophagogastroduodenoscopy EUS endoscopic ultarsound IR interventional radiology LAMS lumen-apposing metal stent PCD percutaneous catheter drainage REFERENCES 1
AD, urticaria, and ACD represent three important allergic dermatologic diseases, the pathogenesis of them is not completely understood